FindTrial
Sign In

concurrent radiotherapy

RADIATION5 trials

Sponsors

The First Affiliated Hospital of Zhengzhou University, University of Pittsburgh, Valley Health System, Changjie Huang, National Cancer Center Hospital East

Conditions

Hepatocellular carcinomaNasopharyngeal CarcinomaNon Small Cell Lung Cancer Stage IIINon-small Cell Lung Cancer Stage IIBPancreatic CancerSuperior Sulcus TumorThymoma

Phase 1

Celecoxib, Irinotecan and Concurrent Radiotherapy in Preoperative Pancreatic Cancer
TerminatedNCT00177853
University of PittsburghPancreatic Cancer
Start: 2006-12-31End: 2010-07-31Target: 23Updated: 2010-07-02

Phase 2

Preoperative Treatment of Patients With High Risk Thymoma
CompletedNCT00387868
Valley Health SystemThymoma
Start: 2006-10-31End: 2014-11-30Updated: 2014-12-09

Phase 3

The Effect of COX-2 Inhibitor on Radiosensitivity in Nasopharyngeal Carcinoma
NCT02537925
Changjie HuangNasopharyngeal Carcinoma
Start: 2014-01-31End: 2016-12-31Target: 120Updated: 2015-09-02
Efficacy and Safety of CRT, Durvalumab and Surgery for SST
Not yet recruitingNCT04465968
National Cancer Center Hospital EastNon-small Cell Lung Cancer Stage IIB, Non Small Cell Lung Cancer Stage III, Superior Sulcus Tumor
Start: 2020-09-01End: 2030-08-31Target: 84Updated: 2020-07-10

Phase 4

A single-arm, open-ended study on the efficacy and safety of donafenib combined with temozolomide and radiotherapy in the treatment of postoperative patients with high-grade glioma
Active, not recruitingChiCTR2100052129
The First Affiliated Hospital of Zhengzhou UniversityHepatocellular carcinoma
Start: 2021-10-18Updated: 2022-06-27

Related Papers

[Application of Neoadjuvant Immuno-chemotherapy in NSCLC].
2021-04-015 citations
Induction chemoradiotherapy followed by resection for locally advanced Masaoka stage III and IVA thymic tumors.
2008-02-0195 citations